Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy
about
(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma.
P2860
Prostate cancer with lytic bone metastases: 18F-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and monitoring response to medical castration therapy
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prostate cancer with lytic bon ...... to medical castration therapy
@en
type
label
Prostate cancer with lytic bon ...... to medical castration therapy
@en
prefLabel
Prostate cancer with lytic bon ...... to medical castration therapy
@en
P2093
P2860
P356
P1476
Prostate cancer with lytic bon ...... to medical castration therapy
@en
P2093
Chandrasekhar Bal
Punit Sharma
Rakesh Kumar
Sachin Jain
Varun Singh Dhull
P2860
P304
P356
10.4103/0972-3919.119545
P577
2013-07-01T00:00:00Z